#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14448	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2407	734.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1601	1601	C	948	C	948	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24650	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4122	743.7	0	.	n	.	0	T695C	SNP	695	695	T	1169	1169	C	921	C,A,T	918,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24650	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4122	743.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1811	1811	A	1000	A,G	999,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24650	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4122	743.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2445	2445	C	830	C	829	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24650	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4122	743.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2519	2519	A	805	A,G	804,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24650	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4122	743.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3071	3071	C	868	C,T	867,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2174	folP	855	855	100.0	folP.l15.c17.ctg.1	2116	128.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1359	1361	AGC	209;207;206	A;G;C,G	208;207;205,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5154	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3902	164.6	1	SNP	p	S91F	1	.	.	271	273	TTC	837	839	TTC	204;206;209	T,G;T;C	203,1;206;209	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5154	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3902	164.6	1	SNP	p	G95N	0	.	.	283	285	GGC	849	851	GGC	218;219;219	G;G,C;C	218;218,1;219	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5154	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3902	164.6	1	SNP	p	D95G	1	.	.	283	285	GGC	849	851	GGC	218;219;219	G;G,C;C	218;218,1;219	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1952	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1783	136.1	1	SNP	p	G45D	0	.	.	133	135	GGC	749	751	GGC	212;212;211	G;G,T;C	212;211,1;211	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1070	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1595	83.5	0	.	n	.	0	A197.	DEL	197	197	A	892	892	A	222	A	222	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4986	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3391	183.3	1	SNP	p	D86N	0	.	.	256	258	GAC	807	809	GAC	194;198;196	G;A;C	194;198;196	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4986	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3391	183.3	1	SNP	p	S87R	1	.	.	259	261	CGT	810	812	CGT	201;202;200	C,A;G,A;T	199,2;201,1;200	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4986	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3391	183.3	1	SNP	p	R87W	0	.	.	259	261	CGT	810	812	CGT	201;202;200	C,A;G,A;T	199,2;201,1;200	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4986	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3391	183.3	1	SNP	p	R87I	0	.	.	259	261	CGT	810	812	CGT	201;202;200	C,A;G,A;T	199,2;201,1;200	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4986	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3391	183.3	1	SNP	p	S88P	0	.	.	262	264	TCC	813	815	TCC	203;203;204	T;C,T;C	203;202,1;204	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4276	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3118	170.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1736	1738	GGC	250;250;251	G,T,A;G,A,T;C,A	248,1,1;248,1,1;250,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1530	1532	GCA	227;228;230	G,C;C;A	226,1;228;230	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1533	1535	ATC	228;226;222	A;T;C	228;226;222	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1545	1547	GTG	207;207;207	G;T,G;G	207;206,1;207	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1545	1547	GTG	207;207;207	G;T,G;G	207;206,1;207	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2049	2051	ACC	233;232;229	A,T,C;C;C	230,2,1;232;229	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2103	2105	GCG	220;223;224	G;C;G,C	220;223;223,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2103	2105	GCG	220;223;224	G;C;G,C	220;223;223,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2226	2228	AGC	199;197;198	A;G;C	199;197;198	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2235	2237	GGC	198;198;201	G,A;G;C	197,1;198;201	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3856	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2956	162.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2253	2255	CCG	210;209;205	C;C;G	210;209;205	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5304	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3601	183.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1950	1952	CCG	192;196;194	C,T;C,T,A;G	191,1;194,1,1;194	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2474	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2382	129.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	917	917	C	175	C	175	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	12	14	TTA	23;25;27	T;T;A	23;25;27	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	57	59	CAT	41;41;41	C;A;T	41;41;41	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	60	62	AGT	41;41;41	A;G,T;T	41;40,1;41	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	69	71	TAC	41;41;41	T,C;A;C	40,1;41;41	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	R307A	NONSYN	919	921	AGA	159	161	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	K309N	NONSYN	925	927	AAA	165	167	AAC	1;1;1	A;A;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	171	173	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	174	176	GAC	1;1;1	G;A;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	180	182	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	186	188	TCG	1;1;1	T;C;G	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	192	194	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	195	197	AGC	1;1;1	A;G;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	198	200	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	222	90.09	porB1a.l6.c4.ctg.1	273	19.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	204	206	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	100	95.0	porB1a.l6.c4.ctg.4	182	35.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	40;37;34	A;C;G	39;37;33	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	212	porB1a	984	100	95.0	porB1a.l6.c4.ctg.4	182	35.0	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	10;8;8	C;A,G;A	10;7,1;8	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2840	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1968	178.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	684	686	GAA	244;243;244	G;A;A,G	244;243;243,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2840	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1968	178.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	972	974	GAT	241;241;240	G,T;A;T	240,1;241;240	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2840	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1968	178.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1095	1097	TCA	242;243;242	T;C;A	242;243;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2840	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1968	178.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1224	1226	GTC	268;264;264	G,A;T;C	267,1;264;264	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2840	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1968	178.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1554	1556	GCA	226;227;226	G;C;A,C	226;227;225,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2840	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1968	178.9	1	SNP	p	G120K	1	.	.	358	360	AAG	930	932	AAG	229;231;229	A;A,G;G	228;229,1;228	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2840	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1968	178.9	1	SNP	p	D121N	0	.	.	361	363	GAC	933	935	GAC	228;232;235	G;A;C	227;231;234	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2840	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1968	178.9	1	SNP	p	A121D	1	.	.	361	363	GAC	933	935	GAC	228;232;235	G;A;C	227;231;234	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9314	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	5497	211.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1324	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1534	107.8	1	SNP	p	V57M	1	.	.	169	171	ATG	798	800	ATG	232;231;230	A,T;T,G;G	231,1;230,1;230	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
